Skip to main content
Premium Trial:

Request an Annual Quote

Thomson Reuters Provides Access to Life Science Data through Accelrys Software

NEW YORK (GenomeWeb News) — Accelrys will provide its customers access to life sciences content available from Thomson Reuters' Cortellis for Informatics via its Enterprise Platform and related Accelrys software offerings including Pipeline Pilot, Symyx Notebook by Accelrys, and Isentris, the San Diego-based informatics firm said today.

The Accelrys Enterprise Platform provides a service-oriented architecture that enables the integration and deployment of scientific solutions across multiple domains in the lab-to-plant process. Cortellis for Informatics provides web services for investigational drugs, drug targets, ontologies, patents, clinical trials, and analytics in biopharmaceutical research and development. The platform was launched earlier this year.

Matt Hahn, Accelrys' senior vice president and chief technology officer, said in a statement that the agreement provides life scientists with "convenient access to expertly refined content and analysis tools through a single, user-friendly source."

Joseph Donahue, Thomson Reuters' senior vice president, added that the partnership should "offer more options to our mutual customers to access, analyze, and drive actionable decisions from key content."

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.